MedTrace Logo

Valsalva Maneuver in Thyroidectomy

NCT05474261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2022-07-29

No results posted yet for this study

Summary

Bleeding after total thyroidectomy remains a rare event that affects early postoperative morbidity, occurring in 0.3% up to 4.2% of cases. Intraoperative bleeding is an unpleasant complication, and it is often easily manageable though postoperative bleeding may represent a life-threatening condition for the patient.

Between January 2019 to February 2022 , 250 consecutive patients were listed for thyroidectomy. The Investigators selected 178 patients and divided them in two groups based on the execution of the Valsalva Manoeuvre.

The purpose of the investigator is to clarify whether the routine intraoperative execution of a Valsalva manoeuvre (VM) may affect the detection of bleeding that would otherwise remain occult and therefore may manifest in the postoperative period.

Conditions

  • The Role of Valsalva Manoeuvre, in Thyroidectomy to Reduce Postoperative Bleeding

Interventions

PROCEDURE

Valsalva maneuver

Valsalva maneuver: increase intrabdominal pressure

Sponsors & Collaborators

  • University of Foggia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-02-01
Completion
2022-04-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05474261 on ClinicalTrials.gov